Differential gene expression in Ndph-knockout mice in retinal development

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 2, 2009, Pages 906-916

  Schäfer, Nikolaus F ^a   Luhmann, Ulrich F O ^a,b   Feil, Silke ^a   Berger, Wolfgang ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; AMINO ACID TRANSPORTER; ANGIOTENSIN II RECEPTOR LIKE 1 PROTEIN; APOLIPOPROTEIN D; CELL MEMBRANE PROTEIN; PLASMALEMMA VESICLE ASSOCIATED PROTEIN; PROTEIN; PROTEIN NORRIN; REGULATOR PROTEIN; SOLUTE CARRIER FAMILY 38 MEMBER 5; UNCLASSIFIED DRUG; AGTRAP PROTEIN, MOUSE; BETA CATENIN; CARRIER PROTEIN; EYE PROTEIN; MEMBRANE PROTEIN; NDPH PROTEIN, MOUSE; NERVE PROTEIN; PLVAP PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; WNT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; KNOCKOUT MOUSE; MALE; MOUSE; NEWBORN; NONHUMAN; NORRIE DISEASE; PATHOGENESIS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA DEVELOPMENT; WILD TYPE; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; DNA MICROARRAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; RETINA NEOVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANIMALS; APOLIPOPROTEINS D; BETA CATENIN; CAPILLARY PERMEABILITY; CARRIER PROTEINS; EYE PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WNT PROTEINS;

EID: 59449108705     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1731     Document Type: Article

References (56)

1. Warburg M. Norrie's disease. A congenital progressive oculoacoustico-cerebral degeneration. Acta Ophthalmol (Copenh). 1966; 85(suppl):5-147.
2. Berger W, Meindl A, van de Pol TJ, et al. Isolation of a candidate gene for Norrie disease by positional cloning. Nat Genet. 1992;1: 199-203.
3. Chen ZY, Hendriks RW, Jobling MA, et al. Isolation and characterization of a candidate gene for Norrie disease. Nat Genet. 1992;1: 204-208.
4. Berger W, van de Pol D, Warburg M, et al. Mutations in the candidate gene for Norrie disease. Hum Mol Genet. 1992;1:461-465.
5. Berger W. Molecular dissection of Norrie disease. Acta Anat (Basel). 1998;162:95-100.
6. Meindl A, Berger W, Meitinger T, et al. Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins. Nat Genet. 1992;2:139-143.
7. Zaremba J, Feil S, Juszko J, et al. Intrafamilial variability of the ocular phenotype in a Polish family with a missense mutation (A63D) in the Norrie disease gene. Ophthalmic Genet. 1998;19: 157-164.
8. Shastry BS, Hejtmancik JF, Trese MT. Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of familial exudative vitreoretinopathy. Hum Mutat. 1997;9:396-401.
9. Shastry BS, Pendergast SD, Hartzer MK, et al. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol. 1997;115: 651-655.
10. Black GC, Perveen R, Bonshek R, et al. Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet. 1999;8:2031-2035.
11. Chen ZY, Battinelli EM, Fielder A, et al. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet. 1993;5:180-183.
12. Berger W, van de Pol D, Bachner D, et al. An animal model for Norrie disease (ND): gene targeting of the mouse ND gene. Hum Mol Genet. 1996;5:51-59.
13. Richter M, Gottanka J, May CA, et al. Retinal vasculature changes in Norrie disease mice. Invest Ophthalmol Vis Sci. 1998;39:2450-2457.
14. Fruttiger M. Development of the retinal vasculature. Angiogenesis. 2007;10:77-88.
15. Luhmann UF, Lin J, Acar N, et al. Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest Ophthalmol Vis Sci. 2005;46: 3372-3382.
16. Ohlmann AV, Adamek E, Ohlmann A, et al. Norrie gene product is necessary for regression of hyaloid vessels. Invest Ophthalmol Vis Sci. 2004;45:2384-2390.
17. Masckauchan TN, Kitajewski J. Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology (Bethesda). 2006;21:181-188.
18. Feeney SA, Simpson DA, Gardiner TA, et al. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression. Invest Ophthalmol Vis Sci. 2003;44:839-847.
19. Ohlmann A, Scholz M, Goldwich A, et al. Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice. J Neurosci. 2005;25:1701-1710.
20. Robitaille J, MacDonald ML, Kaykas A, et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet. 2002;32:326-330.
21. Toomes C, Bottomley HM, Jackson RM, et al. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet. 2004;74:721-730.
22. Wang Y, Huso D, Cahill H, et al. Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled-4 gene. J Neurosci. 1-7-2001;21:4761-4771.
23. Xu Q, Wang Y, Dabdoub A, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 2004;116:883-895.
24. Stan RV, Kubitza M, and Palade GE. PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci U S A. 1999;96:13203-13207.
25. Hubbell E, Liu WM, Mei R. Robust estimators for expression analysis. Bioinformatics. 2002;18:1585-1592.
26. Draghici S, Khatri P, Tarca AL, et al. A systems biology approach for pathway level analysis. Genome Res. 2007;17:1537-1545.
27. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:3.
28. Mutch DM, Berger A, Mansourian R, et al. The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data. BMC Bioinformatics. 2002;3:17.
29. Luhmann UF. Elucidation of Molecular Pathogenic Mechanisms of Norrie Disease (in German). Berlin: Freie Universität Berlin; 2005. Thesis.
30. Hallmann R, Mayer DN, Berg EL, et al. Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev Dyn. 1995;202:325-332.
31. Masckauchan TN, Agalliu D, Vorontchikhina M, et al. Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell. 2006;17: 5163-5172.
32. Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 2001;61:6050-6054.
33. Niemela H, Elima K, Henttinen T, et al. Molecular identification of PAL-E, a widely used endothelial-cell marker. Blood. 2005;106: 3405-3409.
34. Strickland LA, Jubb AM, Hongo JA, et al. Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF). J Pathol. 2005;206:466-475.
35. Stan RV, Tkachenko E, Niesman IR. PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. Mol Biol Cell. 2004;15:3615-3630.
36. Ioannidou S, Deinhardt K, Miotla J, et al. An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis. Proc Natl Acad Sci U S A. 2006;103:16770-16775.
37. Carson-Walter EB, Hampton J, Shue E, et al. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clin Cancer Res. 2005;11:7643-7650.
38. Salinas PC. Modulation of the microtubule cytoskeleton: a role for a divergent canonical Wnt pathway. Trends Cell Biol. 2007;17: 333-342.
39. Saint-Geniez M, Argence CB, Knibiehler B, et al. The msr/apj gene encoding the apelin receptor is an early and specific marker of the venous phenotype in the retinal vasculature. Gene Expr Patterns. 2003;3:467-472.
40. Kasai A, Shintani N, Oda M, et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun. 2004;325:395-400.
41. Leung WC, Lawrie A, Demaries S, et al. Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration. Circ Res. 2004;95:179-186.
42. Sarjeant JM, Lawrie A, Kinnear C, et al. Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus. Arterioscler Thromb Vasc Biol. 2003;23:2172-2177.
43. Witmer AN, van Blijswijk BC, van Noorden CJ, et al. In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A. J Histochem Cytochem. 2004;52:39-52.
44. Kao LC, Tulac S, Lobo S, et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology. 2002;143:2119-2138.
45. Luhmann UF, Meunier D, Shi W, et al. Fetal loss in homozygous mutant Norrie disease mice: a new role of Norrin in reproduction. Genesis. 2005;42:253-262.
46. Rehm HL, Zhang DS, Brown MC, et al. Vascular defects and sensorineural deafness in a mouse model of Norrie disease. J Neurosci. 2002;22:4286-4292.
47. Hildebrand MS, de Silva MG, Klockars T, et al. Expression of the carrier protein apolipoprotein D in the mouse inner ear. Hear Res. 2005;200:102-114.
48. Ogita T, Hashimoto E, Yamasaki M, et al. Hypoxic induction of adrenomedullin in cultured human umbilical vein endothelial cells. J Hypertens. 2001;19:603-608.
49. Ando K, Fujita,T. Lessons from the adrenomedullin knockout mouse. Regul Pept. 2003;112:185-188.
50. Chini EN, Chini CC, Bolliger C, et al. Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway. Kidney Int. 1997;52:917-925.
51. Matsui H, Shimosawa T, Itakura K, et al. Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia. Circulation. 2004;109:2246-2251.
52. Umapathy NS, Li W, Mysona BA, et al. Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Müller cells. Invest Ophthalmol Vis Sci. 2005;46:3980-3987.
53. Ruether K, van de Pol D, Jaissle G, et al. Retinoschisislike alterations in the mouse eye caused by gene targeting of the Norrie disease gene. Invest Ophthalmol Vis Sci. 1997;38:710-718.
54. Cubelos B, Gonzalez-Gonzalez IM, Gimenez C, et al. Amino acid transporter SNAT5 localizes to glial cells in the rat brain. Glia. 2005;49:230-244.
55. Froyen G, Bauters M, Boyle J, et al. Loss of SLC38A5 and FTSJ1 at Xp11.23 in three brothers with non-syndromic mental retardation due to a microdeletion in an unstable genomic region. Hum Genet. 2007;121:539-547.
56. Bringmann A, Reichenbach A. Role of Müller cells in retinal degenerations. Front Biosci. 2001;6:E72-E92.